Neogen Chemicals Limited
Neogen Chemicals Ltd, incorporated in 1991, manufactures bromine and lithium-based organic and organo-metallic compounds, used in the pharmaceutical, agricultural chemicals, and engineering industries.
What Neogen files
- Important76
- Others65
- Investor Meet46
- Updates38
- Board Meeting22
- Insider Trade11
Here's a concise, retail-friendly summary of Neogen Chemicals' Q1 FY27 earnings presentation: **1. Business Performance:** Neogen Chemicals reported solid Q1 FY27. Consolidated revenue jumped 34% YoY to ₹250.3 Cr, fueled by strong Organolithium sales and higher volumes. Exports made up 30%. Neogen Ionics saw stellar growth, hitting ₹19 Cr revenue...
Neogen Chemicals delivered strong Q4 FY26 consolidated performance, with revenue up 22% to 249 Cr, and full-year revenue growing 11% to 862 Cr. Q4 PAT surged 182% to 15 Cr, while FY26 PAT was 29 Cr (+17%). This growth was fueled by high plant utilization and rising volumes. The Battery...
Neogen Chemicals reported Q3 FY26 consolidated revenue of ₹220 Cr, up 9% YoY, primarily from increased volumes in Organic and Inorganic Chemicals. Neogen Ionics contributed ₹12 Cr. Consolidated PAT, however, dipped 63% YoY to ₹3.7 Cr, impacted by post-fire operating/insurance costs and higher interest expenses for growth and plant reconstruction....
Neogen Chemicals reports robust Q2 FY26 consolidated revenue of ₹208.7 crore, up 8% YoY, with standalone revenue also growing 7% to ₹206.7 crore. Growth was driven by sustained demand in its core business and organolithium portfolio. However, consolidated profit after tax (PAT) saw a significant decline of 69% to ₹3.4...
**Financial Highlights:** Neogen reported resilient Q1 FY26 results. Consolidated Revenue grew 4% to 186.7 Cr, with Standalone up 5% to 184.6 Cr. Despite the Dahej plant fire, EBITDA performance remained steady. Standalone EBITDA rose 9% to 34.7 Cr (18.8% margin), and Standalone PAT increased 2% to 14.2 Cr. **Strategic Initiatives...